• / Free eNewsletters & Magazine
  • / My Account
Home>Biotech IPOs: What to Learn from a Banner Year

Biotech IPOs: What to Learn from a Banner Year

Perspectives Content Submission

Thu, 23 Jan 2014

Published with permission from  Knowledge @ Wharton , Wharton’s online business journal. The data is in, and there is no question that 2013 was the most active year for biotechnology initial public offerings since 2000. During the 12 months ended in December, 38 biotech companies debuted on Wall St

Related Videos

  1. Top Biotech Acquisition Candidates

    2011 was a relatively light year for biotech M&A, but it looks like activity is picking up in 2012.

  2. 5 Signs of Fallout in the Market

    Morningstar markets editor Jeremy Glaser studies possible impacts of the Facebook IPO controversy, struggles and turnarounds at Dell and HP, real economy weakness in the eurozone, and slower sales at Tiffany.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.